Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | CXCR4 | P61073 | 4/20 | 0.41 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | HTR1A | P08908 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27876270 | 0.98 | KDM4E (0.44) | KDM4EALDH1A1CXCR4CXCL12SMN1; SMN2 | |
| SCHEMBL28183858 | 0.98 | KDM4E (0.44) | KDM4EALDH1A1CXCR4CXCL12SMN1; SMN2 | |
| SCHEMBL28057902 | 0.98 | KDM4E (0.46) | KDM4EALDH1A1CXCR4CXCL12SMN1; SMN2 | |
| SCHEMBL21177824 | 0.95 | ALDH1A1 (0.44) | KDM4EALDH1A1CXCR4CXCL12SMN1; SMN2 | |
| SCHEMBL28057909 | 0.90 | KDM4E (0.38) | KDM4EALDH1A1CXCR4SMN1; SMN2HTT | |
| SCHEMBL15121277 | 0.89 | KDM4E (0.41) | KDM4EALDH1A1CXCR4CXCL12CYP1A2 | |
| SCHEMBL28254446 | 0.81 | ALDH1A1 (0.42) | KDM4EALDH1A1CXCR4CXCL12SMN1; SMN2 | |
| SCHEMBL28203621 | 0.75 | ALDH1A1 (0.40) | KDM4EALDH1A1CXCR4SMN1; SMN2HTT | |
| SCHEMBL17733777 | 0.75 | CXCR4 (0.61) | KDM4EALDH1A1CXCR4CXCL12 | |
| SCHEMBL9417435 | 0.75 | CXCR4 (0.61) | KDM4EALDH1A1CXCR4CXCL12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117165169-B | Corrosion-resistant water-based paint for automobiles and preparation process thereof | 东莞市瑞盟涂料有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-115228396-B | Preparation method of nano cerium sol | 宣城市晶和环保新材料科技有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-11850294-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2023-12-26 | — | — | US | claimed |
| CN-116179538-A | High-quality sample pretreatment reagent and method thereof | 苏州白垩纪生物科技有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-116139105-A | Protein nucleic acid nano-particle and preparation method thereof | 中国科学院生物物理研究所 | 2023-05-23 | — | — | CN | claimed |
| US-20220079849-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | FIDELITY DIRECT LENDING LLC, AS ADMINISTRATIVE AGENT | 2022-03-17 | — | — | US | claimed |
| US-11185480-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2021-11-30 | — | — | US | claimed |
| EP-3765036-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | Premier Dental Products Company (US) | 2021-01-20 | — | — | EP | claimed |
| US-10688026-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2020-06-23 | — | — | US | claimed |
| CN-111041487-A | Environment-friendly PCB electroplating rack copper stripping liquid and copper stripping method using same | 苏州天承化工有限公司 | 2020-04-21 | — | — | CN | claimed |
| CN-105669990-A | Preparation method of water dispersive acrylate modified polyisocyanate curing agent | 武汉仕全兴聚氨酯科技股份有限公司 | 2016-06-15 | — | — | CN | claimed |
| CN-105636937-A | Stabilizer for preserving biological samples | BGI SHENZHEN | 2016-06-01 | — | — | CN | claimed |
| CN-103472119-B | To the method for capillary inner wall coating electronic supercharging on-line preconcentration capillary electrophoresis analysis aromatic carboxylic acid | DEZHOU COLLEGE (CN) | 2016-01-20 | — | — | CN | claimed |
| CN-105263503-A | Stable composition containing heparinoid, acute anesthetic and buffer | PARSONS C LOWELL | 2016-01-20 | — | — | CN | claimed |
| CN-104661737-A | Automated solution dispenser | LABMINDS LTD | 2015-05-27 | — | — | CN | claimed |
| CN-103278652-B | Total bilirubin detection reagent | NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO LTD | 2015-04-15 | — | — | CN | claimed |
| CN-104316475-A | Living spore content high throughput detection method based on spectrophotometry method | UNIV SHENZHEN | 2015-01-28 | — | — | CN | claimed |
| CN-103278468-A | Creatinine detection reagent | NINGBO MEDICAL BIOLOG TECHNOLOGY CO LTD | 2013-09-04 | — | — | CN | claimed |
| CN-103278652-A | Total bilirubin detection reagent | NINGBO MEDICAL BIOLOG TECHNOLOGY CO LTD | 2013-09-04 | — | — | CN | claimed |
| CN-102721684-A | Two-step enzyme measuring method and measuring reagent for creatinine in blood serum | NINGBO MEIKANG BIOTECHNOLOGY CO LTD | 2012-10-10 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10688026-B2 | Buffered microencapsulated compositions and methods | LIPA, CHMP4B, APOB | KDM4E 3727/4885ALDH1A1 3890/4885CXCR4 1897/4885 |
| US-11185480-B2 | Buffered microencapsulated compositions and methods | CHMP4B, LIPA, APOB | KDM4E 4210/4885ALDH1A1 3804/4885CXCR4 2380/4885 |
| US-11850294-B2 | Buffered microencapsulated compositions and methods | CHMP4B, LIPA, APOB | KDM4E 4210/4885ALDH1A1 3804/4885CXCR4 2380/4885 |
| US-20220079849-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | CHMP4B, LIPA, APOB | KDM4E 4210/4885ALDH1A1 3804/4885CXCR4 2380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.